ASND — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

6.33

Margin Of Safety %

-25

Put/Call OI Ratio

0.14

EPS Next Q Diff

1.6

EPS Last/This Y

EPS This/Next Y

6.58

Price

228.69

Target Price

284.05

Analyst Recom

1.22

Performance Q

8.39

Upside

-164.3%

Beta

0.51

Ticker: ASND

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	ASND	242.34	0.27	0.17	14784
2026-03-03	ASND	240.22	0.26	0.39	14663
2026-03-04	ASND	241.71	0.26	0.18	14820
2026-03-05	ASND	237.58	0.27	0.48	14861
2026-03-06	ASND	241	0.25	0.17	15062
2026-03-09	ASND	240.1	0.24	0.05	16525
2026-03-10	ASND	240.54	0.23	0.01	17274
2026-03-11	ASND	227.29	0.23	0.14	17458
2026-03-12	ASND	229.01	0.18	0.21	20522
2026-03-13	ASND	229.01	0.18	0.21	20522
2026-03-17	ASND	228.29	0.17	0.03	20922
2026-03-18	ASND	227.53	0.17	0.76	20966
2026-03-19	ASND	223.64	0.17	1.42	20988
2026-03-20	ASND	221.94	0.17	0.15	20966
2026-03-23	ASND	218.07	0.14	0.05	16455
2026-03-24	ASND	215.6	0.14	0.03	16775
2026-03-25	ASND	220.9	0.13	0.69	17019
2026-03-26	ASND	220.43	0.14	0.17	17077
2026-03-27	ASND	216.97	0.13	0.23	17043
2026-03-30	ASND	218.19	0.14	0.44	17125
2026-03-31	ASND	228.72	0.14	2.73	17131
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	ASND	242.03	131.7	398.7	4.65
2026-03-03	ASND	239.06	131.7	395.8	4.65
2026-03-04	ASND	241.48	131.7	398.1	4.65
2026-03-05	ASND	237.34	131.3	394.1	4.53
2026-03-06	ASND	240.70	131.3	401.5	4.53
2026-03-09	ASND	239.96	129.6	396.1	4.52
2026-03-10	ASND	240.72	128.1	396.8	4.52
2026-03-11	ASND	227.54	128.1	383.9	4.52
2026-03-12	ASND	228.79	128.1	385.1	4.52
2026-03-13	ASND	226.03	128.1	382.4	4.52
2026-03-17	ASND	228.30	128.1	384.6	4.52
2026-03-18	ASND	227.50	128.2	383.8	4.56
2026-03-19	ASND	223.72	128.2	380.1	4.56
2026-03-20	ASND	221.88	128.2	378.3	4.56
2026-03-23	ASND	218.26	128.2	374.8	4.56
2026-03-24	ASND	215.68	128.2	372.2	4.56
2026-03-25	ASND	220.63	128.2	377.1	4.56
2026-03-26	ASND	220.61	128.2	377.1	4.56
2026-03-27	ASND	217.16	128.2	373.7	4.56
2026-03-30	ASND	218.19	128.2	374.7	4.56
2026-03-31	ASND	228.69	128.2	385.0	4.56
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	ASND	0.00	1.40	6.25
2026-03-03	ASND	0.00	1.40	6.25
2026-03-04	ASND	0.00	1.40	6.25
2026-03-05	ASND	0.00	1.40	6.25
2026-03-06	ASND	0.00	1.40	6.25
2026-03-09	ASND	0.00	1.41	6.25
2026-03-10	ASND	0.00	1.41	6.25
2026-03-11	ASND	0.00	1.41	6.36
2026-03-12	ASND	0.00	1.41	6.36
2026-03-13	ASND	0.00	1.41	6.36
2026-03-17	ASND	0.00	1.42	6.36
2026-03-18	ASND	0.00	1.42	6.36
2026-03-19	ASND	0.00	1.42	6.36
2026-03-20	ASND	0.00	1.42	6.36
2026-03-23	ASND	0.00	1.42	6.36
2026-03-24	ASND	0.00	1.42	6.36
2026-03-25	ASND	0.00	1.42	6.33
2026-03-26	ASND	0.00	1.42	6.33
2026-03-27	ASND	0.00	1.42	6.33
2026-03-30	ASND	0.00	1.42	6.33
2026-03-31	ASND	0.00	1.42	6.33
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.64

Avg. EPS Est. Current Quarter

0.45

Avg. EPS Est. Next Quarter

0.96

Insider Transactions

Institutional Transactions

1.42

Beta

0.51

Average Sales Estimate Current Quarter

282

Average Sales Estimate Next Quarter

327

Fair Value

171.32

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-60.5

Target Price

284.05

P/E

Forward P/E

18.75

PEG

P/S

17.06

P/B

P/Free Cash Flow

272.88

EPS

-4.2

Average EPS Est. Cur. Y

4.56

EPS Next Y. (Est.)

11.14

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-30.85

Relative Volume

0.85

Return on Equity vs Sector %

112.6

Return on Equity vs Industry %

128.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.09

EBIT Estimation

385

◆ ASND Healthcare

$228.73

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

17/25

Volume

7/15

Valuation

12/20

TP/AR

4/10

Options

6/10

RSI

53.3

Range 1M

46.5%

Sup Dist

5.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

23/30

Estimates

3/20

Inst/Vol

5/15

Options

7/10

EPS Yr

213.2%

EPS NY

150.2%

52W%

84.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +32.6% upside

Quality

8/30

Valuation

11/30

Growth

17/25

Stability

6/10

LT Trend

3/5

Upside

+32.6%

Quality

MoS

-25%

Ascendis Pharma A/S

Sector: Healthcare

Industry: Biotechnology

Employees: 1189

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

ASND

Latest News

—

Caricamento notizie per ASND…

stock quote shares ASND – Ascendis Pharma A/S Stock Price stock today

news today ASND – Ascendis Pharma A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch ASND – Ascendis Pharma A/S yahoo finance google finance

stock history ASND – Ascendis Pharma A/S invest stock market

stock prices ASND premarket after hours

ticker ASND fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ASND

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y